Tag: equity
-
Neuro Disease Start-Up Raises $73M in Early Funds
A new enterprise discovering treatments for neurodegenerative diseases is merging with another start-up and raising $73 million its first venture round.
-
Infographic – Biotech Index Rebounds in Q2
Since mid-May, NBI rose steadily, closing at 5,148 by the end of June, a gain of nine percent for the quarter and eight percent for the year.
-
Precision Cancer Meds Company Raises $43M in Early Funds
A company combining computational genetic analysis and precision medicine discovery for cancer therapies is raising $43 million in its first venture round.
-
Gene Therapy Company Starts-Up, Gains $200M
A new company is underway commercializing research on gene therapies for inherited diseases, staked to an initial investment of $200 million.
-
Infographic – Health Care A.I. Funds Jump in Q1
Venture funding for start-ups providing artificial intelligence services in health care climbed to a record high volume in the first quarter of 2021.
-
New Biotech Creating Precision Cancer Therapies
A biotechnology company began work in public to develop new treatments that target proteins responsible for gene expression, beginning with cancer.
-
Early-Stage Life Science Investment Fund Raises $515M
A new venture investment fund raised $515 million for life science start-ups, and its business incubator partner added five biotechs to its seed round portfolio.
-
Synthetic Bio Company Goes Public in $2.5B Merger
A company developing synthetic biology and engineering tools for biotechnology is becoming a public company through a special-purpose acquisition.
-
New Biotech Developing Synthetic Long-Term RNA
A new enterprise, created by a life science venture capital company, began work on developing therapies with long-acting synthetic RNA.
-
AI Gene Therapy Platform Gains $100M in Early Funds
A company using machine learning to create engineered viruses to deliver gene therapies is raising $100 million in its first venture funding round.